Isao Ito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Isao Ito has a total of 251 co-authors. Here are the top co-authors by number of shared publications:
Toyohiro Hirai
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
17 shared publicationsNobuyoshi Hamao
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
13 shared publicationsIssei Oi
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
11 shared publicationsNaoya Tanabe
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawahara-cho, Sakyo, Kyoto, 606-8507, Japan; Department of Internal Medicine, Ono Municipal Hospital, 973 Tenjincho, Ono, Hyogo, 675-1316, Japan
11 shared publicationsKensuke Nishioka
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyo, Kyoto, 606-8507, Japan
10 shared publicationsHisako Matsumoto
Affiliation Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan
9 shared publications
Latest Publications
- 13 November 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 65 (1) , 101537
Changes in age-specific patterns of household transmission of SARS-CoV-2 over six epidemic waves in 2020–2022: a population-based study in Japan
- 13 November 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 65 (1) , 101537
Changes in age-specific patterns of household transmission of SARS-CoV-2 over six epidemic waves in 2020–2022: a population-based study in Japan
- Open Access
- 14 May 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (4) , 101445
Urinary N-terminal titin fragment as a supplementary marker for frailty in chronic obstructive pulmonary disease
- 14 May 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (4) , 101445
Open AccessUrinary N-terminal titin fragment as a supplementary marker for frailty in chronic obstructive pulmonary disease
- 7 May 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (7) , 102992
High prevalence of depressive symptoms and its impact on quality of life in patients with Mycobacterium avium complex lung disease
- 7 May 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (7) , 102992
High prevalence of depressive symptoms and its impact on quality of life in patients with Mycobacterium avium complex lung disease
- Open Access
- 14 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4)
Exogenous Lipoid Pneumonia Caused by E‐Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case Report
Organic solvents contained in oil and waterproofing sprays, along with glycerin and propylene glycol found in e‐cigarettes, have been reported to trigger exogenous lipoid pneumonia. We report a 30‐year‐old male who developed lipoid pneumonia following exposure to paraffin‐based oil spray, waterproofing spray, and subsequent e‐cigarette use. Initial evaluation suggested occupational asthma due to elevated IgE and fractional exhaled nitric oxide levels, but inhaled corticosteroid therapy was ineffective. Chest computed tomography eventually revealed diffuse ground‐glass opacities, and bronchoalveolar lavage fluid analysis demonstrated lipid‐laden macrophages, confirming the diagnosis. Component analysis indicated that e‐cigarette vapor containing glycerin and propylene glycol was the primary trigger, whereas occupational exposures contributed minimally. The patient was managed with observation without steroid therapy, and symptoms resolved over 4 months with lifestyle modifications, including cessation of e‐cigarette use. This case highlights the combined impact of occupational and lifestyle factors in exogenous lipoid pneumonia and emphasizes the importance of assessing inhaled substances, workplace environment, and e‐cigarette use to determine the cause and guide exposure control.
- 14 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4)
Open AccessExogenous Lipoid Pneumonia Caused by E‐Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case Report
Organic solvents contained in oil and waterproofing sprays, along with glycerin and propylene glycol found in e‐cigarettes, have been reported to trigger exogenous lipoid pneumonia. We report a 30‐year‐old male who developed lipoid pneumonia following exposure to paraffin‐based oil spray, waterproofing spray, and subsequent e‐cigarette use. Initial evaluation suggested occupational asthma due to elevated IgE and fractional exhaled nitric oxide levels, but inhaled corticosteroid therapy was ineffective. Chest computed tomography eventually revealed diffuse ground‐glass opacities, and bronchoalveolar lavage fluid analysis demonstrated lipid‐laden macrophages, confirming the diagnosis. Component analysis indicated that e‐cigarette vapor containing glycerin and propylene glycol was the primary trigger, whereas occupational exposures contributed minimally. The patient was managed with observation without steroid therapy, and symptoms resolved over 4 months with lifestyle modifications, including cessation of e‐cigarette use. This case highlights the combined impact of occupational and lifestyle factors in exogenous lipoid pneumonia and emphasizes the importance of assessing inhaled substances, workplace environment, and e‐cigarette use to determine the cause and guide exposure control.
- 8 August 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (9) , 102789
Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia
- 8 August 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (9) , 102789
Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia
- Open Access
- 4 April 2024
- Published by Taylor & Francis in European Clinical Respiratory Journal
- Vol. 11 (1) , 2335721
Investigation of predictors for in-hospital death or long-term hospitalization in community-acquired pneumonia with risk factors for aspiration
Pneumonia is a leading cause of death worldwide [1]. Specifically, aspiration pneumonia is a common bacterial pneumonia phenotype in the elderly [2]. Its incidence is reported to range from 8.5 to ...
- 4 April 2024
- Published by Taylor & Francis in European Clinical Respiratory Journal
- Vol. 11 (1) , 2335721
Open AccessInvestigation of predictors for in-hospital death or long-term hospitalization in community-acquired pneumonia with risk factors for aspiration
Pneumonia is a leading cause of death worldwide [1]. Specifically, aspiration pneumonia is a common bacterial pneumonia phenotype in the elderly [2]. Its incidence is reported to range from 8.5 to ...
- Open Access
- 13 March 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 225, 107600
Clinical phenotypes of nontuberculous mycobacterial disease by cluster analysis based on pulmonary function
- 13 March 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 225, 107600
Open AccessClinical phenotypes of nontuberculous mycobacterial disease by cluster analysis based on pulmonary function
- Open Access
- 10 January 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-11
Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity
Background: The substantial heterogeneity of clinical presentations in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia still requires robust chest computed tomography analysis to identify high-risk patients. While extension of ground-glass opacity and consolidation from peripheral to central lung fields on chest computed tomography (CT) might be associated with severely ill conditions, quantification of the central-peripheral distribution of ground glass opacity and consolidation in assessments of SARS-CoV-2 pneumonia remains unestablished. This study aimed to examine whether the central-peripheral distributions of ground glass opacity and consolidation were associated with severe outcomes in patients with SARS-CoV-2 pneumonia independent of the whole-lung extents of these abnormal shadows. Methods: This multicenter retrospective cohort included hospitalized patients with SARS-CoV-2 pneumonia between January 2020 and August 2021. An artificial intelligence-based image analysis technology was used to segment abnormal shadows, including ground glass opacity and consolidation. The area ratio of ground glass opacity and consolidation to the whole lung (GGO%, CON%) and the ratio of ground glass opacity and consolidation areas in the central lungs to those in the peripheral lungs (GGO(C/P)) and (CON(C/P)) were automatically calculated. Severe outcome was defined as in-hospital death or requirement for endotracheal intubation. Results: Of 512 enrolled patients, the severe outcome was observed in 77 patients. GGO% and CON% were higher in patients with severe outcomes than in those without. Multivariable logistic models showed that GGO(C/P), but not CON(C/P), was associated with the severe outcome independent of age, sex, comorbidities, GGO%, and CON%. Conclusion: In addition to GGO% and CON% in the whole lung, the higher the ratio of ground glass opacity in the central regions to that in the peripheral regions was, the more severe the outcomes in patients with SARS-CoV-2 pneumonia were. The proposed method might be useful to reproducibly quantify the extension of ground glass opacity from peripheral to central lungs and to estimate prognosis.
- 10 January 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-11
Open AccessArtificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity
Background: The substantial heterogeneity of clinical presentations in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia still requires robust chest computed tomography analysis to identify high-risk patients. While extension of ground-glass opacity and consolidation from peripheral to central lung fields on chest computed tomography (CT) might be associated with severely ill conditions, quantification of the central-peripheral distribution of ground glass opacity and consolidation in assessments of SARS-CoV-2 pneumonia remains unestablished. This study aimed to examine whether the central-peripheral distributions of ground glass opacity and consolidation were associated with severe outcomes in patients with SARS-CoV-2 pneumonia independent of the whole-lung extents of these abnormal shadows. Methods: This multicenter retrospective cohort included hospitalized patients with SARS-CoV-2 pneumonia between January 2020 and August 2021. An artificial intelligence-based image analysis technology was used to segment abnormal shadows, including ground glass opacity and consolidation. The area ratio of ground glass opacity and consolidation to the whole lung (GGO%, CON%) and the ratio of ground glass opacity and consolidation areas in the central lungs to those in the peripheral lungs (GGO(C/P)) and (CON(C/P)) were automatically calculated. Severe outcome was defined as in-hospital death or requirement for endotracheal intubation. Results: Of 512 enrolled patients, the severe outcome was observed in 77 patients. GGO% and CON% were higher in patients with severe outcomes than in those without. Multivariable logistic models showed that GGO(C/P), but not CON(C/P), was associated with the severe outcome independent of age, sex, comorbidities, GGO%, and CON%. Conclusion: In addition to GGO% and CON% in the whole lung, the higher the ratio of ground glass opacity in the central regions to that in the peripheral regions was, the more severe the outcomes in patients with SARS-CoV-2 pneumonia were. The proposed method might be useful to reproducibly quantify the extension of ground glass opacity from peripheral to central lungs and to estimate prognosis.
- Open Access
- 7 December 2023
- Published by Springer Nature in Research Square
Comparison of chest radiological findings between coronavirus disease 2019 pneumonia and anti-melanoma differentiation-associated gene 5 antibody- positive interstitial pneumonia by artificial intelligence-based quantitative computed tomography image analysis
Background Coronavirus disease 2019 (COVID-19) pneumonia and anti-melanoma differentiation-associated gene 5 antibody-positive interstitial pneumonia (MDA5-IP) share many similarities; however, the treatment and management of the two diseases are different. In the early stages of developing a treatment plan, it is crucial to distinguish between the two diseases. This study was conducted to compare the radiological findings between COVID-19 pneumonia and MDA5-IP. Methods We recruited patients with COVID-19 pneumonia between January and June 2020. The control group comprised patients with MDA5-IP admitted between April 2013 and December 2019. Patients with thin-slice computed tomography (CT) images within 2 days of admission were enrolled. The CT images were analyzed using an artificial intelligence-based quantitative CT software program. Radiological findings were classified as faint ground-glass opacity (GGO), GGO, reticulation, consolidation, honeycombing, nodules, hyperlucency, or interlobular septum. The volumes of these radiological findings were compared between the two groups. A classification and regression tree algorithm was used to develop a prediction model to stratify the risk of COVID-19 pneumonia. Results We enrolled 72 and 15 patients in the COVID-19 pneumonia and MDA5-IP group, respectively. Faint GGO and consolidations were observed more extensively in patients with MDA5-IP. The prediction model was developed at cut-off values of faint GGO, < 30%; GGO, ≥ 10%, and consolidation < 1%. This prediction model contributed to changing post-test probability in 26% of cases. Conclusion The COVID-19 group showed fewer faint GGO and consolidation volumes than the MDA5-IP group. We developed a predictive model to stratify the risk of COVID-19 pneumonia.
- 7 December 2023
- Published by Springer Nature in Research Square
Open AccessComparison of chest radiological findings between coronavirus disease 2019 pneumonia and anti-melanoma differentiation-associated gene 5 antibody- positive interstitial pneumonia by artificial intelligence-based quantitative computed tomography image analysis
Background Coronavirus disease 2019 (COVID-19) pneumonia and anti-melanoma differentiation-associated gene 5 antibody-positive interstitial pneumonia (MDA5-IP) share many similarities; however, the treatment and management of the two diseases are different. In the early stages of developing a treatment plan, it is crucial to distinguish between the two diseases. This study was conducted to compare the radiological findings between COVID-19 pneumonia and MDA5-IP. Methods We recruited patients with COVID-19 pneumonia between January and June 2020. The control group comprised patients with MDA5-IP admitted between April 2013 and December 2019. Patients with thin-slice computed tomography (CT) images within 2 days of admission were enrolled. The CT images were analyzed using an artificial intelligence-based quantitative CT software program. Radiological findings were classified as faint ground-glass opacity (GGO), GGO, reticulation, consolidation, honeycombing, nodules, hyperlucency, or interlobular septum. The volumes of these radiological findings were compared between the two groups. A classification and regression tree algorithm was used to develop a prediction model to stratify the risk of COVID-19 pneumonia. Results We enrolled 72 and 15 patients in the COVID-19 pneumonia and MDA5-IP group, respectively. Faint GGO and consolidations were observed more extensively in patients with MDA5-IP. The prediction model was developed at cut-off values of faint GGO, < 30%; GGO, ≥ 10%, and consolidation < 1%. This prediction model contributed to changing post-test probability in 26% of cases. Conclusion The COVID-19 group showed fewer faint GGO and consolidation volumes than the MDA5-IP group. We developed a predictive model to stratify the risk of COVID-19 pneumonia.
- 20 November 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 220, 107453
Impact of wearing a surgical facemask during exercise on dyspnea in patients with chronic pulmonary infections: A randomized crossover study
- 20 November 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 220, 107453
Impact of wearing a surgical facemask during exercise on dyspnea in patients with chronic pulmonary infections: A randomized crossover study